Parallax Volatility Advisers’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-85,400
Closed -$1.4M – 2687
2022
Q4
$1.4M Sell
85,400
-57,000
-40% -$640K ﹤0.01% 1534
2022
Q3
$1.82M Buy
142,400
+78,400
+123% +$1.16M ﹤0.01% 1464
2022
Q2
$749K Buy
+64,000
New +$395K ﹤0.01% 1750

Other funds holding ALT

Parallax Volatility Advisers's ALT Position: Q4 2021 in Review

Parallax Volatility Advisers sold out of Altimmune (ALT) in Q4 2021, closing a stake of 57,130 shares — an estimated $646K sold.

Parallax Volatility Advisers first reported a position in ALT in Q4 2020 and held it in 3 quarters. The position peaked at $646K in Q3 2021. 102 funds tracked by Wall St. Rank hold ALT as of Q4 2021.

  • Parallax Volatility Advisers reported no remaining Altimmune position as of Q4 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 57,130 Altimmune shares in Q4 2021, an estimated $646K.
  • Parallax Volatility Advisers first reported a position in Altimmune in Q4 2020 and held it in 3 quarters.
  • Parallax Volatility Advisers's Altimmune position peaked at $646K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Altimmune as of Q4 2021.

Based on Parallax Volatility Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.